Sr. Director - Lilly Ventures at Eli Lilly and Company

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Healthcare, Venture CapitalIndustries

Requirements

Strong demonstrable knowledge of Lilly's systems and highly professional ways of working
Good understanding of the drug discovery and development process / high learning agility
Applied scientific expertise and keen interest in assimilating complex data
Demonstrated ability to advance projects and initiatives
Outstanding EQ, problem-solving, analytical, project management, communication, and leadership skills
Highly organized and able to multitask effectively with concurrent processing and implementation of many active discussions at various stages of evaluation and business discussions
Maintenance of highly accurate records of activity through use of in-house information and compliance systems

Responsibilities

Technical evaluation of new partnership opportunities via objective scientific assessment including analysis of patents, scientific literature, and probing discussions with internal Lilly scientists
Identification of key issues and appropriate expertise to facilitate resolution
Focus on delivering and progressing the best external cutting-edge science from biotech companies into the Lilly portfolio
Report to the Head of East Coast Ventures and serve as a key member of the geographic team defining strategy and tactics in the region
Work closely with global team peers in Indianapolis, Boston, San Francisco, San Diego, Europe, and APAC
Source opportunities from strategic venture fund partners and key institutions in prioritized geographies
Lead/co-lead fund interactions and collaborate with other fund and geography leads and management to find, monitor, and progress opportunities
Attend scientific meetings with venture funds, discuss key matters, record company/portfolio updates across several hundred companies, and act upon them
Identify and deliver direct financial investments in high-profile biotech companies
Interact regularly with existing portfolio companies to ensure optimal line of sight and convert relationships into portfolio-facing deals
Build strong relationships with Search and Evaluation colleagues in therapeutic/functional areas and other Corp BD colleagues in transactions
Lead or participate in downstream partnering projects (acquisition or licensing deals) to deliver Lilly pipeline value
Support expanded pillars of external innovation partnering models

Skills

Venture Capital

Biotech Investing

Scientific Evaluation

Strategic Sourcing

Portfolio Management

Fund Management

Innovation Scouting

Healthcare Ecosystems

Life Sciences

Deal Negotiation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free